欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2405/001
药品名称Eltrombopag Teva
活性成分
    • Eltrombopag olamine 25.0 mg
剂型Film-coated tablet
上市许可持有人Teva GmbH, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Netherlands (NL)
    • Bulgaria (BG)
      Eltrombopag Teva 25mg film-coated tablets
    • Ireland (IE)
    • Cyprus (CY)
      Eltrombopag Teva Film-coated tablet 25 mg
    • Austria (AT)
    • Czechia (CZ)
      Eltrombopag Teva
    • France (FR)
    • Romania (RO)
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Slovenia (SI)
    • Italy (IT)
    • Croatia (HR)
    • Greece (GR)
    • Norway (NO)
    • Latvia (LV)
    • Germany (DE)
      Eltrombopag-ratiopharm 25 mg Filmtabletten
    • Lithuania (LT)
      Eltrombopag Teva 25 mg plėvele dengtos tabletės
    • Denmark (DK)
      Eltrombopag Teva
    • Estonia (EE)
许可日期2024/12/04
最近更新日期2025/01/28
药物ATC编码
    • B02BX05 eltrombopag
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase